4/A//SEC Filing
Pearce Catherine 4/A
Accession 0001209191-22-003182
CIK 0001868734other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:21 PM ET
Size
5.8 KB
Accession
0001209191-22-003182
Insider Transaction Report
Form 4/AAmended
Pearce Catherine
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-01-12+26,471→ 26,471 total→ Common Stock (26,471 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]This Form 4 amendment is being filed to correct the original Form 4 filed on January 10, 2022. The Transaction Date was stated incorrectly on the original Form 4.
- [F3]The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
Related Parties
1- filerCIK 0001898815
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:21 PM ET
- Size
- 5.8 KB